Projected Earnings Date: 2022-06-20    (Delayed quote data   2025-06-12)
Last
 0.14
Change
 ⇓ 0.00   (0.00%)
Volume
  6,513
Open
 0.14
High
 0.14
Low
 0.14
8EMA (Daily)
 0.14
40EMA (Daily)
 0.14
50EMA (Daily)
 0.15
STO (Daily)
 20.000
MACD Hist (Daily)
 0.000
8EMA (Weekly)
 0.142
40EMA (Weekly)
 0.50
50EMA (Weekly)
 0.60
STO (Weekly)
 58.857
MACD Hist (Weekly)
 0.070
Progenity Inc is a biotechnology company. It is engaged in developing and commercializing molecular testing products as well as innovating in the field of precision medicine. It utilizes a multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics, to molecular testing products and to the development of a suite of investigational ingestible devices and drug and device combinations designed to provide precise diagnostic sampling and drug delivery solutions. The firm generates its revenue from molecular laboratory tests, principally from the sale of Innatal, Preparent, and pathology molecular testing. The company's operations are carried out in the United States.
optionchance optionchance
Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com